Medical and Science
Perspectives from one Australian team’s search for a COVID-19 vaccine
Medical News: While it may not be here tomorrow, scientists around the world are racing to develop viable COVID-19 vaccine candidates.
In this podcast episode, two Australian researchers from The University of Queensland share how their team identified a lead vaccine candidate from an initial field of 200 in just over 5 weeks.
Dodi Axelson, Head of Communications, Cytiva, Sweden and Conor McKechnie, Vice President Marketing, Cytiva, United Kingdom share the perspectives of:
- Trent Munro, Professor & Senior Group Leader at the Australian Institute for Bioengineering Nanotechnology and
- Keith Chappell, Associate Professor & Affiliate Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology from The University of Queensland.
Discovery Matters is a collection of stories and insights on matters of discovery that advance science and medicines. Brought to you by the curious people at Cytiva.
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech CEOs set agenda for the new year
Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]
MoreNews & Trends - MedTech & Diagnostics
MTAA and PTA CEOs voice outlook for the year ahead
Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]
MoreNews & Trends - Pharmaceuticals
Scathing report exposes Labor’s mismanagement of the PBS
The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]
More